Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Pharmacol Exp Ther ; 293(2): 390-6, 2000 May.
Article in English | MEDLINE | ID: mdl-10773007

ABSTRACT

Previous studies in this laboratory showed that the overexpression of human aldehyde dehydrogenase class-1 (ALDH-1) with a retroviral vector resulted in increased resistance to 4-hydroperoxycyclophosphamide (4-HC), an active metabolite of cyclophosphamide. The present study examined the effect of ALDH-1 antisense RNA expression on ALDH-1 activity and sensitivity to 4-HC toxicity. Three different ALDH-1 cDNAs were synthesized that are either missing the N terminus (N), C terminus (C), or both (NC) and subcloned into the BamHI cloning site of pLXSN retroviral vector in the antisense (AS) orientation (AS-N, AS-C, and AS-NC, respectively). It was demonstrated that the overexpression of each of the AS constructs in K562 leukemic cells and A549 lung cancer cells results in suppression of ALDH-1 mRNA and enzymatic activity. Furthermore, the AS-N and AS-NC were generally more effective than AS-C in reducing the ALDH-1 activity. Both K562 and A549 cells expressing the ALDH-1 AS became significantly more sensitive to 4-HC toxicity as demonstrated by clonogenic and liquid culture assays. The increase in 4-HC sensitivity was in correlation with the degree of suppression of ALDH-1 activity. Moreover, such increase in 4-HC sensitivity, especially with AS-N and AS-NC, was to a similar degree seen with the use of diethylaminobenzaldehyde, a specific inhibitor of ALDH-1. These results indicate that ALDH-1 expression and activity can be specifically and effectively suppressed by AS RNA and lead to increased sensitivity to 4-HC.


Subject(s)
Aldehyde Dehydrogenase/biosynthesis , Antineoplastic Agents/pharmacology , Cyclophosphamide/analogs & derivatives , RNA, Antisense/biosynthesis , Aldehyde Dehydrogenase/genetics , Blotting, Northern , Blotting, Southern , Blotting, Western , Carcinoma, Non-Small-Cell Lung/metabolism , Cyclophosphamide/pharmacology , DNA, Neoplasm/biosynthesis , Genetic Vectors , Humans , Leukemia, Experimental/metabolism , Lung Neoplasms/metabolism , RNA, Messenger/biosynthesis , Transfection/genetics , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...